Risk Stratification - The Initial Triage
- Initial triage uses risk scores to predict Major Adverse Cardiac Events (MACE) and guide therapy (invasive vs. conservative).
- Key Scores:
- HEART Score: For ED chest pain; score ≤3 suggests low MACE risk, consider discharge.
- TIMI Score: For UA/NSTEMI; predicts 14-day mortality.
- GRACE Score: More complex; predicts in-hospital & 6-month mortality.
⭐ A HEART score of 0-3 is associated with a very low risk of MACE, making it a powerful tool for safely discharging patients from the Emergency Department.

ECG Findings - The First Fork
The initial 12-lead ECG is the critical branch point, separating patients into two management pathways: STEMI or NSTE-ACS.
-
STEMI Criteria:
- New ST-elevation (at J-point, ≥2 contiguous leads):
- ≥1 mm in most leads.
- V2-V3: ≥2 mm (men ≥40), ≥2.5 mm (men <40), ≥1.5 mm (women).
- New or presumed-new LBBB.
- New ST-elevation (at J-point, ≥2 contiguous leads):
-
NSTE-ACS Findings:
- ST-depression ≥0.5 mm.
- Deep T-wave inversions ≥1 mm.
- A normal ECG does not rule out ACS.
⭐ A posterior MI (LCA/RCA occlusion) may present with isolated ST depression in V1-V3. Obtain posterior leads (V7-V9) to unmask ST elevation.
Risk Scores - The Numbers Game
-
TIMI Score (Thrombolysis in Myocardial Infarction): Estimates 14-day risk of death, new/recurrent MI, or severe ischemia in UA/NSTEMI.
- 1 point for each of 7 variables:
- Age ≥65 years
- ≥3 CAD risk factors (HTN, HLD, DM, smoking, family Hx)
- Known CAD (stenosis ≥50%)
- Aspirin use in past 7 days
- ≥2 anginal episodes in last 24 hrs
- ST-segment deviation ≥0.5 mm
- Elevated cardiac markers
- Risk: Low (0-2), Intermediate (3-4), High (≥5)
- 1 point for each of 7 variables:
-
GRACE Score (Global Registry of Acute Coronary Events): Predicts in-hospital & 6-month mortality. More complex but more accurate than TIMI.
- Key Inputs: Age, Killip class, systolic BP, heart rate, creatinine, cardiac arrest, ST deviation, elevated enzymes.
⭐ The GRACE score (>140 = high risk) is superior to TIMI for risk stratification and is preferred by ACC/AHA guidelines to guide the timing of invasive strategy (e.g., angiography).
Biomarkers & Labs - The Molecular Clues
- Cardiac Troponins (cTnI, cTnT): Gold standard for myocardial necrosis.
- High-sensitivity (hs-cTn) assays are standard.
- Rise: 2-4 hrs; Peak: 24-48 hrs; Lasts: 7-10 days.
- The change (delta) in serial levels is diagnostic.
- CK-MB: Less specific than troponin.
- Primary use: detecting re-infarction due to faster normalization (48-72 hrs).
- BNP/NT-proBNP: Indicates ventricular stretch; elevated levels correlate with HF risk and mortality.
- Baseline Panel: CBC (anemia), BMP (K+, creatinine), Lipid profile.

⭐ While troponins are superior for initial diagnosis, CK-MB's rapid normalization makes it valuable for diagnosing re-infarction within days of the initial event.
High-Yield Points - ⚡ Biggest Takeaways
- TIMI and GRACE scores are essential tools for ACS risk stratification to guide therapeutic intensity.
- High-risk features mandating an aggressive approach include dynamic ST-T changes, elevated troponins, and hemodynamic instability.
- Advanced age, diabetes, CKD, and known CAD are powerful predictors of adverse outcomes.
- A high GRACE score (>140) or TIMI score (≥3) strongly favors an early invasive strategy.
- Patients with low-risk scores may be managed conservatively.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app